The report analyzes and forecasts the anti-venom market at global and regional levels. The market has been forecast based on volume (Tons) and value (US$ Mn) from 2019 to 2026. The study includes drivers and restraints of the global market. It covers the impact of these drivers and restraints on the demand during the forecast period. The report also highlights opportunities in the market at the global level. For the region and all segments, the sales, revenue and their market share, growth rate are key research objects; we can research the manufacturers' sales, price, revenue, cost and gross profit and their changes. What's more, we will display the main consumers, raw material manufacturers, distributors, etc.
This report first introduces the background of anti-venom, including the definition, classification, application, industrial chain structure, industry overview, national policy and planning analysis of the industry, and the latest dynamic analysis. With regard to production bases and technologies, the research in this report covers the production time, base distribution, technical parameters, research and development trends, technology sources, and sources of raw materials of major anti-venom companies.
Regarding the analysis of the industry chain, the research of this report covers the raw materials and equipment of anti-venom upstream, downstream customers, marketing channels, industry development trends and investment strategy recommendations. The more specific analysis also includes the main application areas of anti-venom and consumption, major regions and consumption, major global producers, distributors, raw material suppliers, equipment providers and their contact information, industry chain relationship analysis.
The report comprises a detailed value chain analysis, which provides a comprehensive view of the global anti-venom market. The Porter’s Five Forces model has also been included to help understand the competitive landscape of the market. The study encompasses market attractiveness analysis, wherein various applications have been benchmarked based on their market size, growth rate, and general attractiveness.
The study provides a decisive view of the anti-venom market by segmenting it in terms of form and application. The segment has been analyzed based on the present and future trends. Regional segmentation includes the current and projected demand in North America, Europe, Asia Pacific, Latin America, and Middle East & Africa.
The report provides size (in terms of volume and value) of anti-venom market for the base year 2018 and the forecast between 2019 and 2026. Market numbers have been estimated based on form and application. Market size and forecast for each application segment have been provided for the global and regional market.
Companies Mentioned in Report
The report profiles key manufacturers in the anti-venom market based on various attributes such as company details, SWOT analysis, strategic overview, financials, and business overview. Major players profiled in this report include CSL Behring, Bharat Serums and Vaccines Ltd., Haffkine Bio-Pharmaceutical Corporation Ltd, Vacsera, Vins Bioproducts Limited, Rare Therapeutics, etc.
The anti-venom market has been segmented as follows:
Research Methodology:
In-depth interviews and discussions were conducted with several key market participants and opinion leaders to compile the research report.
Primary research represents a bulk of research efforts, supplemented by extensive secondary research. Annual reports, press releases, and relevant documents of key players operating in various application areas have been reviewed for competition analysis and market understanding.
Secondary research also includes recent trends, technical writing, Internet sources, and statistical data from government websites, trade associations, and agencies. These have proved to be reliable, effective, and successful approaches for obtaining precise market data, capturing market participants’ insights, and recognizing business opportunities.
The study objectives of this report are:
Chapter 1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
Chapter 2. Assumptions and Research Methodology
Chapter 3. Executive Summary: Global Anti-venom Market
Chapter 4. Market Overview
4.1. Introduction
4.1.1. Anti-Venom Type Definition
4.1.2. Industry Evolution / Developments
4.2. Market Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.3.4. Trends
4.4. Anti-venom Market Analysis and Forecast, 2017 – 2026
4.4.1. Pricing – Actuals and Projections, 2017-2026 (US$)
4.4.2. Market Revenue Projections (US$ Mn)
4.5. Porter’s Five Force Analysis
4.6. Value Chain Analysis
4.7. Market Outlook
Chapter 5. Global Anti-venom Market Analysis and Forecasts, By Anti-Venom Type
5.1. Introduction & Definition
5.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
5.2.1. Monovalent
5.2.2. Polyvalent
5.3. Market Attractiveness By Anti-Venom Type
5.4. Key Trends
Chapter 6. Global Anti-venom Market Analysis and Forecasts, By Product Type
6.1. Introduction & Definition
6.2. Market Size (US$ Mn) Forecast By Product Type
6.2.1. Snake Anti-Venom
6.2.2. Scorpion Anti-Venom
6.2.3. Spider Anti-Venom
6.2.4. Others
6.3. Market Attractiveness By Product Type
6.4. Key Trends
Chapter 7. Global Anti-venom Market Analysis and Forecasts, By Distribution Channel
7.1. Introduction & Definition
7.2. Market Size (US$ Mn) Forecast By Distribution Channel
7.2.1. Hospitals
7.2.2. Clinics
7.2.3. Ambulatory Surgical centers
7.2.4. Others
7.3. Market Attractiveness By Distribution Channel
7.4. Key Trends
Chapter 8. Global Anti-venom Market Analysis and Forecasts, By Region
8.1. Introduction & Definition
8.2. Market Size (US$ Mn) Forecast By Region
8.2.1. North America
8.2.2. Latin America
8.2.3. Europe
8.2.4. Asia Pacific
8.2.5. Middle East and Africa
8.3. Market Attractiveness By Region
8.4. Key Trend
Chapter 9. North America Anti-venom Market Analysis and Forecast
9.1. Introduction
9.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
9.2.1. Monovalent
9.2.2. Polyvalent
9.3. Market Size (US$ Mn) Forecast By Product Type
9.3.1. Snake Anti-Venom
9.3.2. Scorpion Anti-Venom
9.3.3. Spider Anti-Venom
9.3.4. Others
9.4. Market Size (US$ Mn) Forecast By Distribution Channel
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Ambulatory Surgical centers
9.4.4. Others
9.5. Market Size (US$ Mn) Forecast, By Country
9.5.1. U.S.
9.5.2. Canada
9.6. Market Attractiveness Analysis
9.6.1. By Anti-Venom Type
9.6.2. By Product Type
9.6.3. By Distribution Channel
9.6.4. By Country
9.7. Key Trend
Chapter 10. Europe Anti-venom Market Analysis and Forecast
10.1. Introduction
10.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
10.2.1. Monovalent
10.2.2. Polyvalent
10.3. Market Size (US$ Mn) Forecast By Product Type
10.3.1. Snake Anti-Venom
10.3.2. Scorpion Anti-Venom
10.3.3. Spider Anti-Venom
10.3.4. Others
10.4. Market Size (US$ Mn) Forecast By Distribution Channel
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Ambulatory Surgical centers
10.4.4. Others
10.5. Market Size (US$ Mn) Forecast, By Country
10.5.1. U.K.
10.5.2. France
10.5.3. Germany
10.5.4. Spain
10.5.5. Rest of Europe
10.6. Market Attractiveness Analysis
10.6.1. By Anti-Venom Type
10.6.2. By Product Type
10.6.3. By Distribution Channel
10.6.4. By Country
10.7. Key Trend
Chapter 11. Asia Pacific Anti-venom Market Analysis and Forecast
11.1. Introduction
11.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
11.2.1. Monovalent
11.2.2. Polyvalent
11.3. Market Size (US$ Mn) Forecast By Product Type
11.3.1. Snake Anti-Venom
11.3.2. Scorpion Anti-Venom
11.3.3. Spider Anti-Venom
11.3.4. Others
11.4. Market Size (US$ Mn) Forecast By Distribution Channel
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Ambulatory Surgical centers
11.4.4. Others
11.5. Market Size (US$ Mn) Forecast, By Country
11.5.1. Japan
11.5.2. China
11.5.3. India
11.5.4. Rest of APAC
11.6. Market Attractiveness Analysis
11.6.1. By Anti-Venom Type
11.6.2. By Product Type
11.6.3. By Distribution Channel
11.6.4. By Country
11.7. Key Trend
Chapter 12. Latin America Anti-venom Market Analysis and Forecast
12.1. Introduction
12.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
12.2.1. Monovalent
12.2.2. Polyvalent
12.3. Market Size (US$ Mn) Forecast By Product Type
12.3.1. Snake Anti-Venom
12.3.2. Scorpion Anti-Venom
12.3.3. Spider Anti-Venom
12.3.4. Others
12.4. Market Size (US$ Mn) Forecast By Distribution Channel
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Ambulatory Surgical centers
12.4.4. Others
12.5. Market Size (US$ Mn) Forecast, By Country
12.5.1. Brazil
12.5.2. Mexico
12.5.3. Argentina
12.5.4. Rest of Latin America
12.6. Market Attractiveness Analysis
12.6.1. By Anti-Venom Type
12.6.2. By Product Type
12.6.3. BY Distribution Channel
12.6.4. By Country
12.7. Key Trend
Chapter 13. Middle East & Africa Anti-venom Market Analysis and Forecast
13.1. Introduction
13.2. Market Size (US$ Mn) Forecast By Anti-Venom Type
13.2.1. Monovalent
13.2.2. Polyvalent
13.3. Market Size (US$ Mn) Forecast By Product Type
13.3.1. Snake Anti-Venom
13.3.2. Scorpion Anti-Venom
13.3.3. Spider Anti-Venom
13.3.4. Others
13.4. Market Size (US$ Mn) Forecast By Distribution Channel
13.4.1. Hospitals
13.4.2. Clinics
13.4.3. Ambulatory Surgical centers
13.4.4. Others
13.5. Market Size (US$ Mn) Forecast, By Country
13.5.1. South Africa
13.5.2. Saudi Arabia
13.5.3. Rest of MEA
13.6. Market Attractiveness Analysis
13.6.1. By Anti-Venom Type
13.6.2. By Product Type
13.6.3. BY Distribution Channel
13.6.4. By Country
13.7. Key Trend
Chapter 14. Competition Landscape
14.1. Company Profiles (Details – Overview, Financials, Recent Developments, Strategy)
14.1.1. CSL Behring
14.1.1.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.1.2. Product Portfolio
14.1.1.3. SWOT Analysis
14.1.1.4. Strategic Overview
14.1.2. Bharat Serums and Vaccines Ltd
14.1.2.1. Company Overview (HQ, Business Segments, Employee Strength)
14.1.2.2. Product Portfolio
14.1.2.3. SWOT Analysis
14.1.2.4. Strategic Overview
14.1.3. Haffkine Bio-Pharmaceutical Corporation Ltd
14.1.3.1. Company Overview
14.1.3.2. Product Portfolio
14.1.3.3. SWOT Analysis
14.1.3.4. Financial Overview
14.1.3.5. Strategic Overview
14.1.4. Vacsera
14.1.4.1. Company Overview
14.1.4.2. Product Portfolio
14.1.4.3. SWOT Analysis
14.1.4.4. Financial Overview
14.1.4.5. Strategic Overview
14.1.5. Vins Bioproducts Limited
14.1.5.1. Company Overview
14.1.5.2. Product Portfolio
14.1.5.3. SWOT Analysis
14.1.5.4. Financial Overview
14.1.5.5. Strategic Overview
14.1.6. Rare Disease Therapeutics, Inc.
14.1.6.1. Company Overview
14.1.6.2. Product Portfolio
14.1.6.3. SWOT Analysis
14.1.6.4. Financial Overview
14.1.6.5. Strategic Overview
14.1.7. Bharat Biotech
14.1.7.1. Company Overview
14.1.7.2. Product Portfolio
14.1.7.3. SWOT Analysis
14.1.7.4. Financial Overview
14.1.7.5. Strategic Overview
14.1.8. BTG International Ltd.
14.1.8.1. Company Overview
14.1.8.2. Product Portfolio
14.1.8.3. SWOT Analysis
14.1.8.4. Financial Overview
14.1.8.5. Strategic Overview
Chapter 15. Key Takeaways
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers